Use of labetalol in hypertensive patients during discontinuation of clonidine therapy T. RosenthalB. RabinowitzH. N. Neufeld Originals Pages: 237 - 240
The electrophysiological effects of intravenous Labetalol in man A. HarleyH. A. Coverdale Originals Pages: 241 - 244
Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease H. J. JürgensenJ. Dalsgaard-NielsenJ. Gormsen Originals Pages: 245 - 250
Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension E. B. PedersenH. J. KornerupP. Bjerregaard Originals Pages: 251 - 258
Effect of minoxidil on sympathetic nervous activity in clonidine-treated hypertensive patients M. VelascoA. Urbina-QuintanaO. Hernández-Pieretti Originals Pages: 259 - 262
Influence of two non-steroidal anti-inflammatory drugs on lipolysis and on plasma post-heparin lipoprotein lipase activity in normal man D. BonfiglioliD. SommarivaA. Fasoli Originals Pages: 263 - 267
Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate U. AbshagenG. BetzienB. Kaufmann Originals Pages: 269 - 275
A comparison of the bioavailability and potency of dexamethasone phosphate and sulphate in man S. MiyaboT. NakamuraS. Kishida Originals Pages: 277 - 282
Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man T. B. VreeY. A. HeksterW. T. Friesen Originals Pages: 283 - 292
Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure D. R. BevanJ. D. SouzaR. L. Smith Originals Pages: 293 - 298
Pharmacokinetic concepts — Drug binding, apparent volume of distribution and clearance M. GibaldiJ. R. Koup Originals Pages: 299 - 305
Gas chromatographic — Mass spectrometric determination of dixyrazine in human blood G. BranteS. JönssonA. Melander Originals Pages: 307 - 310
Controlled trials — A social challenge R. BurkhardtG. KienleD. R. Laurence Originals Pages: 311 - 319